
Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients
Key Points:
- Analyzes survival benefits, quality of life, and complication risks associated with ICD implantation in elderly patients.
- Differentiates between primary and secondary prophylactic ICD use, considering comorbidities and life expectancy.
- Provides evidence-based insights to guide clinicians in optimizing ICD therapy decisions for aging populations.
Description
Benefit of Primary and Secondary Prophylactic Implantable Cardioverter Defibrillator in Elderly Patients explores the role of ICD therapy in preventing sudden cardiac death in older adults. This study examines the clinical effectiveness, risks, and patient selection criteria for both primary and secondary prevention strategies.
Reviews
There are no reviews yet.